Has Maha Dawood, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,793 in general payments to Maha Dawood, MD across 856 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Maha Dawood, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Maha Dawood, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Maha Dawood, MD

Rheumatology · Warner Robins, GANPI 1730166851

Payments from drug & device makers

$14,793in general payments, 2019–2025

Across 856 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$3K
Amgen$2K
Johnson & Johnson$1K
Pfizer$845
Novartis$819
UCB, Inc.$743
plus $7K from 39 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	146	$2,650
Amgen(2 entities)	92	$1,615
Johnson & Johnson(2 entities)	72	$1,455
Pfizer	50	$845
Novartis	50	$819
UCB, Inc.	44	$743
AstraZeneca(2 entities)	38	$678
Aurinia Pharma U.S., Inc.	77	$666
GSK	41	$653
Lilly USA, LLC	32	$592
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	36	$551
Genentech USA, Inc.	19	$269
Sanofi	13	$251
Mallinckrodt Hospital Products Inc.	7	$237
Takeda Pharmaceuticals U.S.A., Inc.	12	$219
Intercept Pharmaceuticals, Inc.	10	$208
E.r. Squibb & Sons, L.L.C.	12	$204
Evoke Pharma, Inc.	10	$175
Ardelyx, Inc.	11	$160
Merck	7	$153
Enterra Medical, Inc.	2	$134
QOL Medical, LLC	4	$127
Regeneron Healthcare Solutions, Inc.	4	$117
Braintree Laboratories, Inc.	6	$114
Mallinckrodt Enterprises LLC	6	$104
Ironwood Pharmaceuticals, Inc	6	$100
Redhill Biopharma Inc.	6	$95
Organon	4	$85
Gilead	4	$84
Boehringer Ingelheim	4	$83
Fresenius Kabi USA, LLC	4	$79
ANI Pharmaceuticals, Inc.	3	$77
Scilex Pharmaceuticals Inc.	3	$65
Nestle Healthcare Nutrition Inc.	4	$64
Aimmune Therapeutics, Inc.	3	$62
Hikma Pharmaceuticals USA	4	$59
Pharming Healthcare, Inc.	2	$43
Medtronic	1	$33
Sobi, Inc	1	$26
EMD Serono, Inc.	1	$25
Alnylam Pharmaceuticals Inc.	1	$22
Orphalan Inc	1	$18
Sanofi-aventis U.S. LLC	1	$17
Actelion Pharmaceuticals US, Inc.	1	$17
Phathom Pharmaceuticals, Inc.	1	$2

How this compares

$14,793 in reported general payments places this provider in the 70th percentile of 177 rheumatology providers in Georgia.

See all rheumatology providers in Georgia →

Medicare billing

Part B allowed, 2024

$184,934

Medicare patients

478

Services billed

1,530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Warner Robins

Theresa Lawrence FordLawrenceville$2.9M
Wambui MachuaAtlanta$1.8M
Brent FlickingerGainesville$1.6M
James MossellTifton$1.6M
Roel QuerubinMarietta$1.5M
Arezou KhosroshahiAtlanta$1.5M
Sung LimAtlanta$1.3M
Gary MyersonAtlanta$1.3M
Jefrey LiebermanDecatur$761K
Marta BognarGainesville$719K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →